Navigation Links
Indian Health Minister interested to import bird flu vaccine

Following high level meeting between Indian Prime Minister Dr. Manmohan Singh and Union Health Minister Anbumani Ramadoss// on measures to be taken for facing a bird flu epidemic in India, Health Minister Anbumani Ramadoss Tuesday said India would import the Tamiflu vaccine to prevent bird flu in the country. Following earlier directions from WHO to India to step up necessary precautionary measures in India to face if there are any possible flu attack.

Earlier on October 17th Dr. Anbumani said the Ministry had set up a facility to manufacture influenza vaccine and for the production-cum-procurement of anti-viral drugs and he has said that when the need arises we will go in for vaccine preparation in the country but we will have enough stock of medicine and the vaccine could be made at government-manufacturing units such as the Central Research Institute, Kasauli. Now he has said that the vaccine is not available in India and the government is planning to import the vaccines.

Speaking to reporters at the airport here, Ramadoss urged people not to panic over reports about the spread of bird flu and said his ministry was in touch with the ministries of animal husbandry, human resource development and environment to coordinate adequate preventive measures. The health ministry was also in touch with the World Health Organization and the Indian Council for Medical Research to keep a close watch on the situation, he said.

In the earlier meeting he has said that a committee has been constituted to look into the manufacture of Generic drugs for treating avian flu and the Government could cancel patents during emergencies as provided under the law. No reports of generic drugs for avian flu were discussed in his today’s speech.

(IANS)

Medindia on Bird Flu

Avian influenza (AI) or Bird Flu is a disease of viral etiology that ranges from a mild or even asymptomatic infection to an acute, fatal disease of ch
'"/>




Page: 1 2

Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Indian Doctor granted US patent on organ regeneration
4. Heart attack kills one in every 10 Indians
5. Indian Cherry: Richest Source of Vitiamin C
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. An Indian Bride with signs of SARS
8. Are Indians aware of SARS ?
9. Indians Stay Away from Coke, Pepsi After Toxin Scare
10. Indian pharma industry upbeat on WTO drug deal
11. Indian Treatment for Iraqi Babies
Post Your Comments:
(Date:7/18/2008)...wswire/ -- In the last ten years over 360,children... average of 36,per year, according to a study by M...ces., (See video from General Motors (NYSE: GM...y=35362 ) Hyperthermia is the overheating of the ...s a car can become for a small child in just a few...
(Date:7/18/2008)...uly 18 /PRNewswire-USNewswire/ -- Two consumer,gro...controversial patent,on human embryonic stem cells...(WARF)., Consumer Watchdog, formerly The Foundati...c Patent Foundation appealed to the U.S. Patent,Of... examiner narrowed,WARF,s patent after the two gro...
(Date:7/18/2008)... New research led by a Michigan State University ...rweight workers are lazier, more emotionally unsta...l weight" colleagues. , With the findings, emplo...based stereotypes when it comes to hiring, promoti...or of human resource management, and two colleague...
(Date:7/18/2008)...Newswire/ -- Highmark Blue Cross Blue Shield,Unit...s will join forces to,promote healthy smiles and l...and continuing until 3 p.m., tomorrow, July 19, a ...al screenings, restorations and sealants,for those...ived much less attention in,American culture than ...
Breaking Medicine News(10 mins):Health News:Consumer Groups File Appeal on Challenge of Human Stem Cell Patent Held By WARF 2Health News:Studies refute common stereotypes about obese workers 2Health News:Highmark Blue Cross Blue Shield, United Concordia and Catholic Charities Join Forces to Offer Free Health, Dental Services This Saturday 2
...students gathered for a live chat with Indian Amer...xciting to view her as she spoke from her zero-gra...ds and necklace floating loosely, a scientific fac...fore. It was equally thrilling to be able to see ...
...en have you relied on your instincts or ‘gut-feel’...about time you do, because a recent study has rein...reliable beacon. A study conducted by the Unive...e in the journal, Current Biology, has shown the w...
...be still far from reality, but the very idea is bo...d the possibility of administering insulin orally/...sulin is given via injections or via inhalation li...ists from Taiwan’s National Tsing Hua University h...
...ton – The last ten years have witnessed a surge in...rtray//. The data shows that the number of surger... 64 age group and by 726 percent among patients be...res which are clubbed under the technical name, ba...
Other Medicine News:Health News:Indian Students Thrilled to Talk to Sunita Williams 2
(Date:7/16/2008)... of men rank discomfort as #1 reason to avoid disc...to heart disease, INDIANAPOLIS, July 16 /PRNewswi...2 percent of men with erectile dysfunction (ED) su...h conditions, such as heart,disease and diabetes, ...on,with their doctors. The survey, conducted by Ip...
(Date:7/16/2008)... Raptor to Support Phase 2a Clinical Trial at UCS... -- Raptor,Pharmaceuticals Corp. ("Raptor" or the ...nced the execution of a collaboration agreement (t... San Diego ("UCSD") to,include a Phase 2a clinical...f cysteamine bitartrate ("Cysteamine") in adolesce...
(Date:7/15/2008)... July 15 /PRNewswire-USNewswire/ -- A man sufferin...ian Hospital of Dallas ER and was,eventually treat... cardiac,catheterization lab in 28 minutes. The pr...ventional cardiologist at Presbyterian, involved u...ery and illustrates the,importance of providing tr...
(Date:7/15/2008)...- Company Reports Favorable Phase 1 RX-3341 Result...b-X Pharmaceuticals, Inc.,("Rib-X" or the "Company...covery and development of novel antibiotics for th...day announced the initiation of a Phase,2 clinical...und RX-3341 in,the treatment of complicated skin a...
Breaking Medicine Technology:The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 2The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 3The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 4The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 5Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 3Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 4Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 5Record 'Door-to-Balloon' Time at Presbyterian Hospital of Dallas 2Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 2Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 3USP announces 2008 summer internship program participants 17031 1USP announces 2008 summer internship program participants 17031 2More Than 350 Events Today in Recognition of First National Healthcare Decisions Day 17030 1More Than 350 Events Today in Recognition of First National Healthcare Decisions Day 17030 2Aflac Incorporated To Release First Quarter Results on April 23 2008 17028 1Aflac Incorporated To Release First Quarter Results on April 23 2008 17028 2Torchmark Corporation Reports First Quarter 2008 Results 17026 1Torchmark Corporation Reports First Quarter 2008 Results 17026 2Torchmark Corporation Reports First Quarter 2008 Results 17026 3Torchmark Corporation Reports First Quarter 2008 Results 17026 4Torchmark Corporation Reports First Quarter 2008 Results 17026 5Torchmark Corporation Reports First Quarter 2008 Results 17026 6Torchmark Corporation Reports First Quarter 2008 Results 17026 7Torchmark Corporation Reports First Quarter 2008 Results 17026 8Torchmark Corporation Reports First Quarter 2008 Results 17026 9
... /PRNewswire-FirstCall/ -,MIGENIX Inc. , a clinica... will make a presentation of results from a recent...ee April 11, 2007,press release) in a non-responde...W) 2007 being held in Washington, DC May 19-24,20...atitis,Investigative Unit (VHIU) at the Health Sci...
...swire-FirstCall/ -- A total,of 20 oral and poster ...ough,s hepatitis products, including PEGINTRON(TM)..., USP) combination,therapy for chronic hepatitis C... 503034), the company,s investigational oral HCV,p...evelopment, will,be presented by leading researche...
Other Medicine Technology:Migenix to Present Celgosivir Phase II Hepatitis C Results at,Digestive Disease Week 2007 2Migenix to Present Celgosivir Phase II Hepatitis C Results at,Digestive Disease Week 2007 3Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 2Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 3Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 4Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 5Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 6Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 7
Each handle is designed to fit a specific trephine size.
Each handle is designed to fit a specific trephine size.
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons.
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons.
Medicine Products: